Literature DB >> 12720161

Human monoclonal macroglobulins with antibody activity.

Marvin J Stone1, Yolonda G McElroy, Alan Pestronk, Janet L Reynolds, Joseph T Newman, Alex W Tong.   

Abstract

Assays for specific antigen-binding activity were performed on sera from 172 patients with monoclonal macroglobulinemia defined by immunofixation electrophoresis. The sera were collected between 1970 and 2002. Mean IgM level was 1,409 mg/dL with a range from 70 to 6,800. Cryoglobulins were identified in 15.3% (26/170 sera: 12 trace, five single component, and nine mixed IgM-IgG). Rheumatoid factor (RF) was detected in 19 of 151 (12.6%) samples with titers ranging from 1:80 to 1:327,680. Among the nine mixed IgM-IgG cryos, eight were RF-positive and six of six displayed positivity for hepatitis C virus. Cold agglutinins (CA) were present in 8.5% (10/117) of sera with anti-I titers between 1:512 and 1:65,536. IgM binding to a series of glycosaminoglycan oligosaccharides, glycolipids, and glycoprotein antigens was found in 75 samples (43%). IgM binding to antigens having known associations to polyneuropathies occurred in 20 patients (12%). Antinuclear antibody (ANA) was documented in 10.7% (18/169) of sera. Anti-DNA activity was absent in all samples tested. Sera from 71% of patients with monoclonal macroglobulinemia in this series exhibited binding to autoantigens. Some of these immune complexes resulted in clinically significant manifestations. Our results suggest that many monoclonal immunoglobulins may be functional antibodies rather than "paraproteins." Characterization of antigen-binding activities may provide insight into the pathogenesis of monoclonal gammopathies. Copyright 2003 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12720161     DOI: 10.1053/sonc.2003.50077

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  11 in total

1.  Pathophysiology of Waldenström's macroglobulinemia.

Authors:  Marvin J Stone; Virginia Pascual
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

2.  Resolution of Serologic Problems Due to Cold Agglutinins in Chronic Lymphocytic Leukemia.

Authors:  Rizwan Javed; Suvro Sankha Datta; Sabita Basu; Anupam Chakrapani
Journal:  Indian J Hematol Blood Transfus       Date:  2016-01-20       Impact factor: 0.900

3.  Peripheral neuropathies in Waldenström's macroglobulinaemia.

Authors:  T Levine; A Pestronk; J Florence; M T Al-Lozi; G Lopate; T Miller; I Ramneantu; W Waheed; M Stambuk; M J Stone; R Choksi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

4.  Successful treatment of refractory cold hemagglutinemia in MYD88 L265P mutation-negative Waldenström's macroglobulinemia with bortezomib.

Authors:  Mayuko Izumi; Hiroko Tsunemine; Yasuhiro Suzuki; Akihiro Tomita; Toshiko Kusumoto; Taiichi Kodaka; Kiminari Itoh; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2015-03-21       Impact factor: 2.490

Review 5.  Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Authors:  Sigbjørn Berentsen; Tatjana Sundic
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

Review 6.  Role of Complement in Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Transfus Med Hemother       Date:  2015-09-07       Impact factor: 3.747

7.  A novel method for demonstrating cold agglutinin disease: a case report.

Authors:  Thomas A Vo; Zack Oakey; Yasir A Khan; Donald S Minckler
Journal:  J Med Case Rep       Date:  2018-04-18

Review 8.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

Review 9.  Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Authors:  Sigbjørn Berentsen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Hematology       Date:  2007-10       Impact factor: 2.269

Review 10.  Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.

Authors:  Siegfried Janz
Journal:  ISRN Hematol       Date:  2013-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.